Today's Earnings: TDW, BDSX, INTT, CMPX, URG
From the desk of the Editor
Dear Reader,
We just identified several stocks that are expected to release earnings very soon.
If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.
Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Sponsor Message
Game-Changing Cancer Tech Nears FDA Completion
In the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection.
Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about.
FDA review is in its final stages and it could become the gold standard before we know it.
Explore Investment Opportunities in This Market Disruptor
Tidewater Inc.
Symbol: TDW
Recent Price: $70.37
Average Analyst Price Target: $88.25 (25.41%)
Market Cap: $3.72B
Last Year's EPS: $0.43
Consensus EPS Forecast: $1.45
Expected Earnings Date: Mar 01, 2024
Recent Analyst Action: Don Crist, analyst at Johnson Rice, reiterates coverage on Tidewater Inc. (TDW) in the Energy sector with a Buy rating and a price target of $88 (2 weeks ago).
TipRanks.comalso reports thatTidewater Inc.currently has4analysts offering 12-month price targets and the consensus is aBuyrating with an average price target is$88.25 .The target pricing ranges from a high forecast of $90down to a low forecast of$85.Tidewater Inc. (TDW)’s last closing price was$70.37 which would put the average price target at25.41% upside.
Here are 3rd party ratings for TDW:
TipRanks.com: Buy
TradingView.com: Buy
Yahoo! Finance: Bearish Short-Term Outlook
Barchart.com: Strong buy
Zacks.com: Hold, Bottom 9% (228 out of 250)
Sponsor Message
Transform your 401K with Gold (free guide)
Market volatility could wipe out your 401K overnight. But if you roll that over into a Gold IRA (which saves you money and taxes), you could actually grow your wealth instead.
Download this free gold guide from America’s #1 gold company to take control of your financial future in these uncertain times.
Act now for a safer, more stable investment.
Claim your free gold guide today!
Biodesix, Inc.
Symbol:BDSX
Recent Price:$1.53
Average Analyst Price Target:$3.50 (128.76%)
Market Cap:$137.98M
Last Year's EPS:$-0.17
Consensus EPS Forecast:$-0.15
ExpectedEarningsDate:Mar 01, 2024
Recent Analyst Action: Kyle Mikson, analyst at Canaccord Genuity, reiterates coverage on Biodesix, Inc. (BDSX) in the Healthcare sector with a Buy rating and a price target of $3.5 (2 months ago).
TipRanks.comalso reports thatBiodesix, Inc.currently has1analysts offering 12-month price targets and the consensus is aBuyrating with an average price target is$3.50 .The target pricing ranges from a high forecast of $3.5down to a low forecast of$3.5.Biodesix, Inc. (BDSX)’s last closing price was$1.53 which would put the average price target at128.76% upside.
Here are 3rd party ratings for BDSX:
TipRanks.com: Buy
TradingView.com: Sell
Yahoo! Finance: Bullish Short-Term Outlook
Barchart.com: Weak buy
Zacks.com: Hold, Top 32% (80 out of 250)
Sponsor Message
Rare Chance to Be an Early Investor in AI Energy Breakthrough
Technology expert Ian King has found a way to invest in the technology powering AI energy.
A breakthrough that presents a once-in-a-lifetime opportunity for fast-acting investors.
Just go here for full details.
inTEST Corporation
Symbol:INTT
Recent Price:$11.53
Average Analyst Price Target:$22.67 (96.59%)
Market Cap:$140.22M
Last Year's EPS:$0.28
Consensus EPS Forecast:$0.25
ExpectedEarningsDate:Mar 01, 2024
Recent Analyst Action: Jaeson Schmidt, analyst at Lake Street, reiterates coverage on inTEST Corporation (INTT) in the Technology sector with a Buy rating and a price target of $19 (2 days ago).
TipRanks.comalso reports thatinTEST Corporationcurrently has3analysts offering 12-month price targets and the consensus is aBuyrating with an average price target is$22.67 .The target pricing ranges from a high forecast of $29down to a low forecast of$19.inTEST Corporation (INTT)’s last closing price was$11.53 which would put the average price target at96.59% upside.
Here are 3rd party ratings for INTT:
TipRanks.com: Buy
TradingView.com: Sell
Yahoo! Finance: Bullish Short-Term Outlook
Barchart.com: Strong sell
Zacks.com: Hold, Bottom 28% (179 out of 250)
--------------------------------------------------------------------------
Compass Therapeutics, Inc.
Symbol:CMPX
Recent Price:$1.74
Average Analyst Price Target:$9.00 (417.24%)
Market Cap:$221.83M
Last Year's EPS:$-0.09
Consensus EPS Forecast:$-0.11
ExpectedEarningsDate:Mar 01, 2024
Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on Compass Therapeutics, Inc. (CMPX) in the Healthcare sector with a Buy rating and a price target of $10 (1 month ago).
TipRanks.comalso reports thatCompass Therapeutics, Inc.currently has2analysts offering 12-month price targets and the consensus is aBuyrating with an average price target is$9.00 .The target pricing ranges from a high forecast of $8down to a low forecast of$10.Compass Therapeutics, Inc. (CMPX)’s last closing price was$1.74 which would put the average price target at417.24% upside.
Here are 3rd party ratings for CMPX:
TipRanks.com: Buy
TradingView.com: Buy
Yahoo! Finance: Neutral Short-Term Outlook
Barchart.com: Weak sell
Zacks.com: Buy, Top 34% (85 out of 250)
Sponsor Message
My Gift to You
I have arranged for you to receive a complimentary 3-month subscription to Bernie Schaeffer’s Option Advisor online newsletter.
CLICK HERE
for 3 Months FREE of
Bernie Schaeffer’s Option Advisor
($395 Retail Value - FREE!)
Ur-Energy Inc.
Symbol:URG
Recent Price:$1.57
Average Analyst Price Target:$2.74 (74.36%)
Market Cap:$417.60M
Last Year's EPS:$-0.03
Consensus EPS Forecast:$-0.00438
ExpectedEarningsDate:Mar 01, 2024
Recent Analyst Action: Matt Key, analyst at B.Riley Financial, reiterates coverage on Ur-Energy Inc. (URG) in the Energy sector with a Buy rating and a price target of $3 (3 weeks ago).
TipRanks.comalso reports thatUr-Energy Inc.currently has4analysts offering 12-month price targets and the consensus is aBuyrating with an average price target is$2.74 .The target pricing ranges from a high forecast of $3down to a low forecast of$2.5.Ur-Energy Inc. (URG)’s last closing price was$1.57 which would put the average price target at74.36% upside.
Here are 3rd party ratings for URG:
TipRanks.com: Buy
TradingView.com: Sell
Yahoo! Finance: Neutral Short-Term Outlook
Barchart.com: buy
Zacks.com: Buy, Bottom 41% (147 out of 250)
Sponsor Message
Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer.
Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds.
This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
Learn More Now - Before Anticipated FDA Approval in 2024
And there you have it--- Stocks expected to release earnings soon...